医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2013年
34期
244-245
,共2页
肠炎宝合剂%抑菌
腸炎寶閤劑%抑菌
장염보합제%억균
Chang Yan Bao Mixture%inhibitor
目的：对肠炎宝合剂体外抑菌作用的研究，为其治疗溃疡性结肠炎提供依据。方法：考察肠炎宝合剂和复方黄连素对大肠杆菌和痢疾杆菌的最小抑菌浓度（MIC）和最小杀菌浓度（MBC）。结果：肠炎宝合剂对大肠杆菌和痢疾杆菌的MIC分别是152μg/ml和174μg/ml，MBC分别是332μg/ml和363μg/ml；复方黄连素片对大肠杆菌和痢疾杆菌的MIC分别是168μg/ml和172μg/ml，MBC分别是349μg/ml和351μg/ml。两药作用强度相近。结论：肠炎宝合剂具有明显的抑菌、杀菌作用。
目的：對腸炎寶閤劑體外抑菌作用的研究，為其治療潰瘍性結腸炎提供依據。方法：攷察腸炎寶閤劑和複方黃連素對大腸桿菌和痢疾桿菌的最小抑菌濃度（MIC）和最小殺菌濃度（MBC）。結果：腸炎寶閤劑對大腸桿菌和痢疾桿菌的MIC分彆是152μg/ml和174μg/ml，MBC分彆是332μg/ml和363μg/ml；複方黃連素片對大腸桿菌和痢疾桿菌的MIC分彆是168μg/ml和172μg/ml，MBC分彆是349μg/ml和351μg/ml。兩藥作用彊度相近。結論：腸炎寶閤劑具有明顯的抑菌、殺菌作用。
목적：대장염보합제체외억균작용적연구，위기치료궤양성결장염제공의거。방법：고찰장염보합제화복방황련소대대장간균화이질간균적최소억균농도（MIC）화최소살균농도（MBC）。결과：장염보합제대대장간균화이질간균적MIC분별시152μg/ml화174μg/ml，MBC분별시332μg/ml화363μg/ml；복방황련소편대대장간균화이질간균적MIC분별시168μg/ml화172μg/ml，MBC분별시349μg/ml화351μg/ml。량약작용강도상근。결론：장염보합제구유명현적억균、살균작용。
Objective: To study the bacteriostasis of Chang Yan Bao Mixture to prove the bacteria inhibiting and kil ing effectiveness in vitro. Methods: Respectively detect the drug concentration of Chang Yan Bao Mixture and berberine to Escherichia coli and Shigel a dysenteriae. Compare the difference of the minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) between the two therapeutic drugs. Results: To the Escherichia coli, the MIC and MBC of Chang Yan Bao Mixture is 152μg/ml and 332μg/ml. The MIC and MBC of Chang Yan Bao Mixture to Shigel a dysenteriae is 174μg/ml, 363μg/ml. Both of them are similar to results of berberine. Conclusion: Beside berberine, Chang Yan Bao Mixture is another effective bacteria inhibitor and kil er.
